Global Immunodiagnostics
Global Immunodiagnostics

Immunodiagnostics Comprehensive Study by Type (Reagents, Instruments, Software & Services), Application (Oncology and Endocrinology, Hepatitis and Retrovirus Testing, Infectious Disease Testing, GI Stool Testing), Technology (Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay, Rapid Test, Others), End User (Clinical laboratories, Hospitals, Academic & Research Centers, Pharmaceutical & Biotechnology Industry, Others) Players and Region - Global Market Outlook to 2026

Immunodiagnostics Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Feb 2021 Edition 223 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Immunodiagnostics Market Overview:
Immunodiagnostics is the branch of in vitro diagnostics that deals with the diagnosis of several diseases on the basis of antigen antibody reaction. Its a primary means for diagnosing infectious disease, chronic diseases such as cancer and cardiovascular diseases, autoimmunity diseases, and endocrinology among others. The significant advancement in the immunodiagnostics technologies have enhanced the ability to target the areas to diagnose disease progression. The growth in development has improved the diagnosis of complex diseases. Some of the players profiled in the study are Abbott Laboratories (United States), Biomérieux SA (France), Danaher Corporation (United States), Thermo Fisher Scientific (United States), F. Hoffmann-La Roche Ltd. (Switzerland), OraSure Technologies Inc. (United States), Quest Diagnostics Inc. (United States), Siemens AG (Germany), Sysmex Corp. (Japan) and Tecan Group Ltd. (Switzerland).

On the basis of geography, the market of Immunodiagnostics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Technology, the sub-segment i.e. Enzyme-Linked Immunosorbent Assay will boost the Immunodiagnostics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Clinical laboratories will boost the Immunodiagnostics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Growth Drivers
  • Rise in incidences of infectious diseases (HIV, STI, hepatitis B, and others), cardiovascular diseases, cancer, gastrointestinal, and other chronic diseases

Influencing Trend
  • Technological advancement in diagnosis kits, assays and analysers

Restraints
  • Inadequate reimbursements hindering the growth of the market

Opportunities
  • Increase in awareness of the preventive health measures among the patients and medical professionals

Challenges
  • Lack of awareness regarding immunodiagnostics




Global immunodiagnostics market is is highly competitive and consists of a limited number of vendors who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant growth opportunities for the market in forecast years.

Target Audience:
New Entrants/Investors, Analysts and Strategic Business Planners, Immunodiagnostics Provider, Government Regulatory, Research Organizations and End Users

Major Objectives Focused through this Study
• To define, describe, and forecast the Global Immunodiagnostics market on the basis of product [Reagents, Instruments and Software & Services] , application [Oncology and Endocrinology, Hepatitis and Retrovirus Testing, Infectious Disease Testing and GI Stool Testing], key regions and end user
• To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
• To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
• Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
• To provide market size for various segments of the Immunodiagnostics market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
• To strategically profile the key players and analyzing their market shares and core competencies in the Immunodiagnostics industry
• To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are .
** Confirmation on availability of data would be informed prior purchase

While framing the research framework, major and emerging players operating in the Immunodiagnostics market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.
Report Objectives / Segmentation Covered
By Type
  • Reagents
  • Instruments
  • Software & Services
By Application
  • Oncology and Endocrinology
  • Hepatitis and Retrovirus Testing
  • Infectious Disease Testing
  • GI Stool Testing
By Technology
  • Enzyme-Linked Immunosorbent Assay
  • Chemiluminescence Immunoassay
  • Fluorescent Immunoassay
  • Radioimmunoassay
  • Rapid Test
  • Others

By End User
  • Clinical laboratories
  • Hospitals
  • Academic & Research Centers
  • Pharmaceutical & Biotechnology Industry
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rise in incidences of infectious diseases (HIV, STI, hepatitis B, and others), cardiovascular diseases, cancer, gastrointestinal, and other chronic diseases
    • 3.3. Market Challenges
      • 3.3.1. Lack of awareness regarding immunodiagnostics
    • 3.4. Market Trends
      • 3.4.1. Technological advancement in diagnosis kits, assays and analysers
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Immunodiagnostics, by Type, Application, Technology, End User and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Immunodiagnostics (Value)
      • 5.2.1. Global Immunodiagnostics by: Type (Value)
        • 5.2.1.1. Reagents
        • 5.2.1.2. Instruments
        • 5.2.1.3. Software & Services
      • 5.2.2. Global Immunodiagnostics by: Application (Value)
        • 5.2.2.1. Oncology and Endocrinology
        • 5.2.2.2. Hepatitis and Retrovirus Testing
        • 5.2.2.3. Infectious Disease Testing
        • 5.2.2.4. GI Stool Testing
      • 5.2.3. Global Immunodiagnostics by: Technology (Value)
        • 5.2.3.1. Enzyme-Linked Immunosorbent Assay
        • 5.2.3.2. Chemiluminescence Immunoassay
        • 5.2.3.3. Fluorescent Immunoassay
        • 5.2.3.4. Radioimmunoassay
        • 5.2.3.5. Rapid Test
        • 5.2.3.6. Others
      • 5.2.4. Global Immunodiagnostics by: End User (Value)
        • 5.2.4.1. Clinical laboratories
        • 5.2.4.2. Hospitals
        • 5.2.4.3. Academic & Research Centers
        • 5.2.4.4. Pharmaceutical & Biotechnology Industry
        • 5.2.4.5. Others
      • 5.2.5. Global Immunodiagnostics Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Immunodiagnostics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Biomérieux SA (France)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Danaher Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Thermo Fisher Scientific (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. F. Hoffmann-La Roche Ltd. (Switzerland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. OraSure Technologies Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Quest Diagnostics Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Siemens AG (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sysmex Corp. (Japan)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Tecan Group Ltd. (Switzerland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Immunodiagnostics Sale, by Type, Application, Technology, End User and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Immunodiagnostics (Value)
      • 7.2.1. Global Immunodiagnostics by: Type (Value)
        • 7.2.1.1. Reagents
        • 7.2.1.2. Instruments
        • 7.2.1.3. Software & Services
      • 7.2.2. Global Immunodiagnostics by: Application (Value)
        • 7.2.2.1. Oncology and Endocrinology
        • 7.2.2.2. Hepatitis and Retrovirus Testing
        • 7.2.2.3. Infectious Disease Testing
        • 7.2.2.4. GI Stool Testing
      • 7.2.3. Global Immunodiagnostics by: Technology (Value)
        • 7.2.3.1. Enzyme-Linked Immunosorbent Assay
        • 7.2.3.2. Chemiluminescence Immunoassay
        • 7.2.3.3. Fluorescent Immunoassay
        • 7.2.3.4. Radioimmunoassay
        • 7.2.3.5. Rapid Test
        • 7.2.3.6. Others
      • 7.2.4. Global Immunodiagnostics by: End User (Value)
        • 7.2.4.1. Clinical laboratories
        • 7.2.4.2. Hospitals
        • 7.2.4.3. Academic & Research Centers
        • 7.2.4.4. Pharmaceutical & Biotechnology Industry
        • 7.2.4.5. Others
      • 7.2.5. Global Immunodiagnostics Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Immunodiagnostics: by Type(USD Million)
  • Table 2. Immunodiagnostics Reagents , by Region USD Million (2015-2020)
  • Table 3. Immunodiagnostics Instruments , by Region USD Million (2015-2020)
  • Table 4. Immunodiagnostics Software & Services , by Region USD Million (2015-2020)
  • Table 5. Immunodiagnostics: by Application(USD Million)
  • Table 6. Immunodiagnostics Oncology and Endocrinology , by Region USD Million (2015-2020)
  • Table 7. Immunodiagnostics Hepatitis and Retrovirus Testing , by Region USD Million (2015-2020)
  • Table 8. Immunodiagnostics Infectious Disease Testing , by Region USD Million (2015-2020)
  • Table 9. Immunodiagnostics GI Stool Testing , by Region USD Million (2015-2020)
  • Table 10. Immunodiagnostics: by Technology(USD Million)
  • Table 11. Immunodiagnostics Enzyme-Linked Immunosorbent Assay , by Region USD Million (2015-2020)
  • Table 12. Immunodiagnostics Chemiluminescence Immunoassay , by Region USD Million (2015-2020)
  • Table 13. Immunodiagnostics Fluorescent Immunoassay , by Region USD Million (2015-2020)
  • Table 14. Immunodiagnostics Radioimmunoassay , by Region USD Million (2015-2020)
  • Table 15. Immunodiagnostics Rapid Test , by Region USD Million (2015-2020)
  • Table 16. Immunodiagnostics Others , by Region USD Million (2015-2020)
  • Table 17. Immunodiagnostics: by End User(USD Million)
  • Table 18. Immunodiagnostics Clinical laboratories , by Region USD Million (2015-2020)
  • Table 19. Immunodiagnostics Hospitals , by Region USD Million (2015-2020)
  • Table 20. Immunodiagnostics Academic & Research Centers , by Region USD Million (2015-2020)
  • Table 21. Immunodiagnostics Pharmaceutical & Biotechnology Industry , by Region USD Million (2015-2020)
  • Table 22. Immunodiagnostics Others , by Region USD Million (2015-2020)
  • Table 23. South America Immunodiagnostics, by Country USD Million (2015-2020)
  • Table 24. South America Immunodiagnostics, by Type USD Million (2015-2020)
  • Table 25. South America Immunodiagnostics, by Application USD Million (2015-2020)
  • Table 26. South America Immunodiagnostics, by Technology USD Million (2015-2020)
  • Table 27. South America Immunodiagnostics, by End User USD Million (2015-2020)
  • Table 28. Brazil Immunodiagnostics, by Type USD Million (2015-2020)
  • Table 29. Brazil Immunodiagnostics, by Application USD Million (2015-2020)
  • Table 30. Brazil Immunodiagnostics, by Technology USD Million (2015-2020)
  • Table 31. Brazil Immunodiagnostics, by End User USD Million (2015-2020)
  • Table 32. Argentina Immunodiagnostics, by Type USD Million (2015-2020)
  • Table 33. Argentina Immunodiagnostics, by Application USD Million (2015-2020)
  • Table 34. Argentina Immunodiagnostics, by Technology USD Million (2015-2020)
  • Table 35. Argentina Immunodiagnostics, by End User USD Million (2015-2020)
  • Table 36. Rest of South America Immunodiagnostics, by Type USD Million (2015-2020)
  • Table 37. Rest of South America Immunodiagnostics, by Application USD Million (2015-2020)
  • Table 38. Rest of South America Immunodiagnostics, by Technology USD Million (2015-2020)
  • Table 39. Rest of South America Immunodiagnostics, by End User USD Million (2015-2020)
  • Table 40. Asia Pacific Immunodiagnostics, by Country USD Million (2015-2020)
  • Table 41. Asia Pacific Immunodiagnostics, by Type USD Million (2015-2020)
  • Table 42. Asia Pacific Immunodiagnostics, by Application USD Million (2015-2020)
  • Table 43. Asia Pacific Immunodiagnostics, by Technology USD Million (2015-2020)
  • Table 44. Asia Pacific Immunodiagnostics, by End User USD Million (2015-2020)
  • Table 45. China Immunodiagnostics, by Type USD Million (2015-2020)
  • Table 46. China Immunodiagnostics, by Application USD Million (2015-2020)
  • Table 47. China Immunodiagnostics, by Technology USD Million (2015-2020)
  • Table 48. China Immunodiagnostics, by End User USD Million (2015-2020)
  • Table 49. Japan Immunodiagnostics, by Type USD Million (2015-2020)
  • Table 50. Japan Immunodiagnostics, by Application USD Million (2015-2020)
  • Table 51. Japan Immunodiagnostics, by Technology USD Million (2015-2020)
  • Table 52. Japan Immunodiagnostics, by End User USD Million (2015-2020)
  • Table 53. India Immunodiagnostics, by Type USD Million (2015-2020)
  • Table 54. India Immunodiagnostics, by Application USD Million (2015-2020)
  • Table 55. India Immunodiagnostics, by Technology USD Million (2015-2020)
  • Table 56. India Immunodiagnostics, by End User USD Million (2015-2020)
  • Table 57. South Korea Immunodiagnostics, by Type USD Million (2015-2020)
  • Table 58. South Korea Immunodiagnostics, by Application USD Million (2015-2020)
  • Table 59. South Korea Immunodiagnostics, by Technology USD Million (2015-2020)
  • Table 60. South Korea Immunodiagnostics, by End User USD Million (2015-2020)
  • Table 61. Taiwan Immunodiagnostics, by Type USD Million (2015-2020)
  • Table 62. Taiwan Immunodiagnostics, by Application USD Million (2015-2020)
  • Table 63. Taiwan Immunodiagnostics, by Technology USD Million (2015-2020)
  • Table 64. Taiwan Immunodiagnostics, by End User USD Million (2015-2020)
  • Table 65. Australia Immunodiagnostics, by Type USD Million (2015-2020)
  • Table 66. Australia Immunodiagnostics, by Application USD Million (2015-2020)
  • Table 67. Australia Immunodiagnostics, by Technology USD Million (2015-2020)
  • Table 68. Australia Immunodiagnostics, by End User USD Million (2015-2020)
  • Table 69. Rest of Asia-Pacific Immunodiagnostics, by Type USD Million (2015-2020)
  • Table 70. Rest of Asia-Pacific Immunodiagnostics, by Application USD Million (2015-2020)
  • Table 71. Rest of Asia-Pacific Immunodiagnostics, by Technology USD Million (2015-2020)
  • Table 72. Rest of Asia-Pacific Immunodiagnostics, by End User USD Million (2015-2020)
  • Table 73. Europe Immunodiagnostics, by Country USD Million (2015-2020)
  • Table 74. Europe Immunodiagnostics, by Type USD Million (2015-2020)
  • Table 75. Europe Immunodiagnostics, by Application USD Million (2015-2020)
  • Table 76. Europe Immunodiagnostics, by Technology USD Million (2015-2020)
  • Table 77. Europe Immunodiagnostics, by End User USD Million (2015-2020)
  • Table 78. Germany Immunodiagnostics, by Type USD Million (2015-2020)
  • Table 79. Germany Immunodiagnostics, by Application USD Million (2015-2020)
  • Table 80. Germany Immunodiagnostics, by Technology USD Million (2015-2020)
  • Table 81. Germany Immunodiagnostics, by End User USD Million (2015-2020)
  • Table 82. France Immunodiagnostics, by Type USD Million (2015-2020)
  • Table 83. France Immunodiagnostics, by Application USD Million (2015-2020)
  • Table 84. France Immunodiagnostics, by Technology USD Million (2015-2020)
  • Table 85. France Immunodiagnostics, by End User USD Million (2015-2020)
  • Table 86. Italy Immunodiagnostics, by Type USD Million (2015-2020)
  • Table 87. Italy Immunodiagnostics, by Application USD Million (2015-2020)
  • Table 88. Italy Immunodiagnostics, by Technology USD Million (2015-2020)
  • Table 89. Italy Immunodiagnostics, by End User USD Million (2015-2020)
  • Table 90. United Kingdom Immunodiagnostics, by Type USD Million (2015-2020)
  • Table 91. United Kingdom Immunodiagnostics, by Application USD Million (2015-2020)
  • Table 92. United Kingdom Immunodiagnostics, by Technology USD Million (2015-2020)
  • Table 93. United Kingdom Immunodiagnostics, by End User USD Million (2015-2020)
  • Table 94. Netherlands Immunodiagnostics, by Type USD Million (2015-2020)
  • Table 95. Netherlands Immunodiagnostics, by Application USD Million (2015-2020)
  • Table 96. Netherlands Immunodiagnostics, by Technology USD Million (2015-2020)
  • Table 97. Netherlands Immunodiagnostics, by End User USD Million (2015-2020)
  • Table 98. Rest of Europe Immunodiagnostics, by Type USD Million (2015-2020)
  • Table 99. Rest of Europe Immunodiagnostics, by Application USD Million (2015-2020)
  • Table 100. Rest of Europe Immunodiagnostics, by Technology USD Million (2015-2020)
  • Table 101. Rest of Europe Immunodiagnostics, by End User USD Million (2015-2020)
  • Table 102. MEA Immunodiagnostics, by Country USD Million (2015-2020)
  • Table 103. MEA Immunodiagnostics, by Type USD Million (2015-2020)
  • Table 104. MEA Immunodiagnostics, by Application USD Million (2015-2020)
  • Table 105. MEA Immunodiagnostics, by Technology USD Million (2015-2020)
  • Table 106. MEA Immunodiagnostics, by End User USD Million (2015-2020)
  • Table 107. Middle East Immunodiagnostics, by Type USD Million (2015-2020)
  • Table 108. Middle East Immunodiagnostics, by Application USD Million (2015-2020)
  • Table 109. Middle East Immunodiagnostics, by Technology USD Million (2015-2020)
  • Table 110. Middle East Immunodiagnostics, by End User USD Million (2015-2020)
  • Table 111. Africa Immunodiagnostics, by Type USD Million (2015-2020)
  • Table 112. Africa Immunodiagnostics, by Application USD Million (2015-2020)
  • Table 113. Africa Immunodiagnostics, by Technology USD Million (2015-2020)
  • Table 114. Africa Immunodiagnostics, by End User USD Million (2015-2020)
  • Table 115. North America Immunodiagnostics, by Country USD Million (2015-2020)
  • Table 116. North America Immunodiagnostics, by Type USD Million (2015-2020)
  • Table 117. North America Immunodiagnostics, by Application USD Million (2015-2020)
  • Table 118. North America Immunodiagnostics, by Technology USD Million (2015-2020)
  • Table 119. North America Immunodiagnostics, by End User USD Million (2015-2020)
  • Table 120. United States Immunodiagnostics, by Type USD Million (2015-2020)
  • Table 121. United States Immunodiagnostics, by Application USD Million (2015-2020)
  • Table 122. United States Immunodiagnostics, by Technology USD Million (2015-2020)
  • Table 123. United States Immunodiagnostics, by End User USD Million (2015-2020)
  • Table 124. Canada Immunodiagnostics, by Type USD Million (2015-2020)
  • Table 125. Canada Immunodiagnostics, by Application USD Million (2015-2020)
  • Table 126. Canada Immunodiagnostics, by Technology USD Million (2015-2020)
  • Table 127. Canada Immunodiagnostics, by End User USD Million (2015-2020)
  • Table 128. Mexico Immunodiagnostics, by Type USD Million (2015-2020)
  • Table 129. Mexico Immunodiagnostics, by Application USD Million (2015-2020)
  • Table 130. Mexico Immunodiagnostics, by Technology USD Million (2015-2020)
  • Table 131. Mexico Immunodiagnostics, by End User USD Million (2015-2020)
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Immunodiagnostics: by Type(USD Million)
  • Table 143. Immunodiagnostics Reagents , by Region USD Million (2021-2026)
  • Table 144. Immunodiagnostics Instruments , by Region USD Million (2021-2026)
  • Table 145. Immunodiagnostics Software & Services , by Region USD Million (2021-2026)
  • Table 146. Immunodiagnostics: by Application(USD Million)
  • Table 147. Immunodiagnostics Oncology and Endocrinology , by Region USD Million (2021-2026)
  • Table 148. Immunodiagnostics Hepatitis and Retrovirus Testing , by Region USD Million (2021-2026)
  • Table 149. Immunodiagnostics Infectious Disease Testing , by Region USD Million (2021-2026)
  • Table 150. Immunodiagnostics GI Stool Testing , by Region USD Million (2021-2026)
  • Table 151. Immunodiagnostics: by Technology(USD Million)
  • Table 152. Immunodiagnostics Enzyme-Linked Immunosorbent Assay , by Region USD Million (2021-2026)
  • Table 153. Immunodiagnostics Chemiluminescence Immunoassay , by Region USD Million (2021-2026)
  • Table 154. Immunodiagnostics Fluorescent Immunoassay , by Region USD Million (2021-2026)
  • Table 155. Immunodiagnostics Radioimmunoassay , by Region USD Million (2021-2026)
  • Table 156. Immunodiagnostics Rapid Test , by Region USD Million (2021-2026)
  • Table 157. Immunodiagnostics Others , by Region USD Million (2021-2026)
  • Table 158. Immunodiagnostics: by End User(USD Million)
  • Table 159. Immunodiagnostics Clinical laboratories , by Region USD Million (2021-2026)
  • Table 160. Immunodiagnostics Hospitals , by Region USD Million (2021-2026)
  • Table 161. Immunodiagnostics Academic & Research Centers , by Region USD Million (2021-2026)
  • Table 162. Immunodiagnostics Pharmaceutical & Biotechnology Industry , by Region USD Million (2021-2026)
  • Table 163. Immunodiagnostics Others , by Region USD Million (2021-2026)
  • Table 164. South America Immunodiagnostics, by Country USD Million (2021-2026)
  • Table 165. South America Immunodiagnostics, by Type USD Million (2021-2026)
  • Table 166. South America Immunodiagnostics, by Application USD Million (2021-2026)
  • Table 167. South America Immunodiagnostics, by Technology USD Million (2021-2026)
  • Table 168. South America Immunodiagnostics, by End User USD Million (2021-2026)
  • Table 169. Brazil Immunodiagnostics, by Type USD Million (2021-2026)
  • Table 170. Brazil Immunodiagnostics, by Application USD Million (2021-2026)
  • Table 171. Brazil Immunodiagnostics, by Technology USD Million (2021-2026)
  • Table 172. Brazil Immunodiagnostics, by End User USD Million (2021-2026)
  • Table 173. Argentina Immunodiagnostics, by Type USD Million (2021-2026)
  • Table 174. Argentina Immunodiagnostics, by Application USD Million (2021-2026)
  • Table 175. Argentina Immunodiagnostics, by Technology USD Million (2021-2026)
  • Table 176. Argentina Immunodiagnostics, by End User USD Million (2021-2026)
  • Table 177. Rest of South America Immunodiagnostics, by Type USD Million (2021-2026)
  • Table 178. Rest of South America Immunodiagnostics, by Application USD Million (2021-2026)
  • Table 179. Rest of South America Immunodiagnostics, by Technology USD Million (2021-2026)
  • Table 180. Rest of South America Immunodiagnostics, by End User USD Million (2021-2026)
  • Table 181. Asia Pacific Immunodiagnostics, by Country USD Million (2021-2026)
  • Table 182. Asia Pacific Immunodiagnostics, by Type USD Million (2021-2026)
  • Table 183. Asia Pacific Immunodiagnostics, by Application USD Million (2021-2026)
  • Table 184. Asia Pacific Immunodiagnostics, by Technology USD Million (2021-2026)
  • Table 185. Asia Pacific Immunodiagnostics, by End User USD Million (2021-2026)
  • Table 186. China Immunodiagnostics, by Type USD Million (2021-2026)
  • Table 187. China Immunodiagnostics, by Application USD Million (2021-2026)
  • Table 188. China Immunodiagnostics, by Technology USD Million (2021-2026)
  • Table 189. China Immunodiagnostics, by End User USD Million (2021-2026)
  • Table 190. Japan Immunodiagnostics, by Type USD Million (2021-2026)
  • Table 191. Japan Immunodiagnostics, by Application USD Million (2021-2026)
  • Table 192. Japan Immunodiagnostics, by Technology USD Million (2021-2026)
  • Table 193. Japan Immunodiagnostics, by End User USD Million (2021-2026)
  • Table 194. India Immunodiagnostics, by Type USD Million (2021-2026)
  • Table 195. India Immunodiagnostics, by Application USD Million (2021-2026)
  • Table 196. India Immunodiagnostics, by Technology USD Million (2021-2026)
  • Table 197. India Immunodiagnostics, by End User USD Million (2021-2026)
  • Table 198. South Korea Immunodiagnostics, by Type USD Million (2021-2026)
  • Table 199. South Korea Immunodiagnostics, by Application USD Million (2021-2026)
  • Table 200. South Korea Immunodiagnostics, by Technology USD Million (2021-2026)
  • Table 201. South Korea Immunodiagnostics, by End User USD Million (2021-2026)
  • Table 202. Taiwan Immunodiagnostics, by Type USD Million (2021-2026)
  • Table 203. Taiwan Immunodiagnostics, by Application USD Million (2021-2026)
  • Table 204. Taiwan Immunodiagnostics, by Technology USD Million (2021-2026)
  • Table 205. Taiwan Immunodiagnostics, by End User USD Million (2021-2026)
  • Table 206. Australia Immunodiagnostics, by Type USD Million (2021-2026)
  • Table 207. Australia Immunodiagnostics, by Application USD Million (2021-2026)
  • Table 208. Australia Immunodiagnostics, by Technology USD Million (2021-2026)
  • Table 209. Australia Immunodiagnostics, by End User USD Million (2021-2026)
  • Table 210. Rest of Asia-Pacific Immunodiagnostics, by Type USD Million (2021-2026)
  • Table 211. Rest of Asia-Pacific Immunodiagnostics, by Application USD Million (2021-2026)
  • Table 212. Rest of Asia-Pacific Immunodiagnostics, by Technology USD Million (2021-2026)
  • Table 213. Rest of Asia-Pacific Immunodiagnostics, by End User USD Million (2021-2026)
  • Table 214. Europe Immunodiagnostics, by Country USD Million (2021-2026)
  • Table 215. Europe Immunodiagnostics, by Type USD Million (2021-2026)
  • Table 216. Europe Immunodiagnostics, by Application USD Million (2021-2026)
  • Table 217. Europe Immunodiagnostics, by Technology USD Million (2021-2026)
  • Table 218. Europe Immunodiagnostics, by End User USD Million (2021-2026)
  • Table 219. Germany Immunodiagnostics, by Type USD Million (2021-2026)
  • Table 220. Germany Immunodiagnostics, by Application USD Million (2021-2026)
  • Table 221. Germany Immunodiagnostics, by Technology USD Million (2021-2026)
  • Table 222. Germany Immunodiagnostics, by End User USD Million (2021-2026)
  • Table 223. France Immunodiagnostics, by Type USD Million (2021-2026)
  • Table 224. France Immunodiagnostics, by Application USD Million (2021-2026)
  • Table 225. France Immunodiagnostics, by Technology USD Million (2021-2026)
  • Table 226. France Immunodiagnostics, by End User USD Million (2021-2026)
  • Table 227. Italy Immunodiagnostics, by Type USD Million (2021-2026)
  • Table 228. Italy Immunodiagnostics, by Application USD Million (2021-2026)
  • Table 229. Italy Immunodiagnostics, by Technology USD Million (2021-2026)
  • Table 230. Italy Immunodiagnostics, by End User USD Million (2021-2026)
  • Table 231. United Kingdom Immunodiagnostics, by Type USD Million (2021-2026)
  • Table 232. United Kingdom Immunodiagnostics, by Application USD Million (2021-2026)
  • Table 233. United Kingdom Immunodiagnostics, by Technology USD Million (2021-2026)
  • Table 234. United Kingdom Immunodiagnostics, by End User USD Million (2021-2026)
  • Table 235. Netherlands Immunodiagnostics, by Type USD Million (2021-2026)
  • Table 236. Netherlands Immunodiagnostics, by Application USD Million (2021-2026)
  • Table 237. Netherlands Immunodiagnostics, by Technology USD Million (2021-2026)
  • Table 238. Netherlands Immunodiagnostics, by End User USD Million (2021-2026)
  • Table 239. Rest of Europe Immunodiagnostics, by Type USD Million (2021-2026)
  • Table 240. Rest of Europe Immunodiagnostics, by Application USD Million (2021-2026)
  • Table 241. Rest of Europe Immunodiagnostics, by Technology USD Million (2021-2026)
  • Table 242. Rest of Europe Immunodiagnostics, by End User USD Million (2021-2026)
  • Table 243. MEA Immunodiagnostics, by Country USD Million (2021-2026)
  • Table 244. MEA Immunodiagnostics, by Type USD Million (2021-2026)
  • Table 245. MEA Immunodiagnostics, by Application USD Million (2021-2026)
  • Table 246. MEA Immunodiagnostics, by Technology USD Million (2021-2026)
  • Table 247. MEA Immunodiagnostics, by End User USD Million (2021-2026)
  • Table 248. Middle East Immunodiagnostics, by Type USD Million (2021-2026)
  • Table 249. Middle East Immunodiagnostics, by Application USD Million (2021-2026)
  • Table 250. Middle East Immunodiagnostics, by Technology USD Million (2021-2026)
  • Table 251. Middle East Immunodiagnostics, by End User USD Million (2021-2026)
  • Table 252. Africa Immunodiagnostics, by Type USD Million (2021-2026)
  • Table 253. Africa Immunodiagnostics, by Application USD Million (2021-2026)
  • Table 254. Africa Immunodiagnostics, by Technology USD Million (2021-2026)
  • Table 255. Africa Immunodiagnostics, by End User USD Million (2021-2026)
  • Table 256. North America Immunodiagnostics, by Country USD Million (2021-2026)
  • Table 257. North America Immunodiagnostics, by Type USD Million (2021-2026)
  • Table 258. North America Immunodiagnostics, by Application USD Million (2021-2026)
  • Table 259. North America Immunodiagnostics, by Technology USD Million (2021-2026)
  • Table 260. North America Immunodiagnostics, by End User USD Million (2021-2026)
  • Table 261. United States Immunodiagnostics, by Type USD Million (2021-2026)
  • Table 262. United States Immunodiagnostics, by Application USD Million (2021-2026)
  • Table 263. United States Immunodiagnostics, by Technology USD Million (2021-2026)
  • Table 264. United States Immunodiagnostics, by End User USD Million (2021-2026)
  • Table 265. Canada Immunodiagnostics, by Type USD Million (2021-2026)
  • Table 266. Canada Immunodiagnostics, by Application USD Million (2021-2026)
  • Table 267. Canada Immunodiagnostics, by Technology USD Million (2021-2026)
  • Table 268. Canada Immunodiagnostics, by End User USD Million (2021-2026)
  • Table 269. Mexico Immunodiagnostics, by Type USD Million (2021-2026)
  • Table 270. Mexico Immunodiagnostics, by Application USD Million (2021-2026)
  • Table 271. Mexico Immunodiagnostics, by Technology USD Million (2021-2026)
  • Table 272. Mexico Immunodiagnostics, by End User USD Million (2021-2026)
  • Table 273. Research Programs/Design for This Report
  • Table 274. Key Data Information from Secondary Sources
  • Table 275. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Immunodiagnostics: by Type USD Million (2015-2020)
  • Figure 5. Global Immunodiagnostics: by Application USD Million (2015-2020)
  • Figure 6. Global Immunodiagnostics: by Technology USD Million (2015-2020)
  • Figure 7. Global Immunodiagnostics: by End User USD Million (2015-2020)
  • Figure 8. South America Immunodiagnostics Share (%), by Country
  • Figure 9. Asia Pacific Immunodiagnostics Share (%), by Country
  • Figure 10. Europe Immunodiagnostics Share (%), by Country
  • Figure 11. MEA Immunodiagnostics Share (%), by Country
  • Figure 12. North America Immunodiagnostics Share (%), by Country
  • Figure 13. Global Immunodiagnostics share by Players 2020 (%)
  • Figure 14. Global Immunodiagnostics share by Players (Top 3) 2020(%)
  • Figure 15. Global Immunodiagnostics share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 18. Abbott Laboratories (United States) Revenue: by Geography 2020
  • Figure 19. Biomérieux SA (France) Revenue, Net Income and Gross profit
  • Figure 20. Biomérieux SA (France) Revenue: by Geography 2020
  • Figure 21. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 22. Danaher Corporation (United States) Revenue: by Geography 2020
  • Figure 23. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 24. Thermo Fisher Scientific (United States) Revenue: by Geography 2020
  • Figure 25. F. Hoffmann-La Roche Ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 26. F. Hoffmann-La Roche Ltd. (Switzerland) Revenue: by Geography 2020
  • Figure 27. OraSure Technologies Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. OraSure Technologies Inc. (United States) Revenue: by Geography 2020
  • Figure 29. Quest Diagnostics Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Quest Diagnostics Inc. (United States) Revenue: by Geography 2020
  • Figure 31. Siemens AG (Germany) Revenue, Net Income and Gross profit
  • Figure 32. Siemens AG (Germany) Revenue: by Geography 2020
  • Figure 33. Sysmex Corp. (Japan) Revenue, Net Income and Gross profit
  • Figure 34. Sysmex Corp. (Japan) Revenue: by Geography 2020
  • Figure 35. Tecan Group Ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 36. Tecan Group Ltd. (Switzerland) Revenue: by Geography 2020
  • Figure 37. Global Immunodiagnostics: by Type USD Million (2021-2026)
  • Figure 38. Global Immunodiagnostics: by Application USD Million (2021-2026)
  • Figure 39. Global Immunodiagnostics: by Technology USD Million (2021-2026)
  • Figure 40. Global Immunodiagnostics: by End User USD Million (2021-2026)
  • Figure 41. South America Immunodiagnostics Share (%), by Country
  • Figure 42. Asia Pacific Immunodiagnostics Share (%), by Country
  • Figure 43. Europe Immunodiagnostics Share (%), by Country
  • Figure 44. MEA Immunodiagnostics Share (%), by Country
  • Figure 45. North America Immunodiagnostics Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Abbott Laboratories (United States)
  • Biomérieux SA (France)
  • Danaher Corporation (United States)
  • Thermo Fisher Scientific (United States)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • OraSure Technologies Inc. (United States)
  • Quest Diagnostics Inc. (United States)
  • Siemens AG (Germany)
  • Sysmex Corp. (Japan)
  • Tecan Group Ltd. (Switzerland)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation